Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Journey Medical Corp (DERM) Stock Price & Analysis

121 Followers

DERM Stock Chart & Stats

$4.44$0.02(0.45%)
At close: 4:00 PM EST
$5$6$7$8Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$4.38 - $4.56
52-Week Range
$4.25 - $9.56
Previous Close
$4.42
Volume
N/A
Average Volume (3M)
184.40K
Market Cap
$124.75M
Enterprise Value
$194.55M
Total Cash (Recent Filing)
$25.64M
Total Debt (Recent Filing)
$25.54M
Price to Earnings (P/E)
―
Beta
0.62
Next Earnings
Mar 31, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Product Demand Growth

Double-digit revenue growth led by demand for Amrozi indicates expanding commercial traction rather than reliance solely on cost control. Continued product adoption can improve operating leverage, strengthen the company’s dermatology position, and support more durable earnings growth.

Improving Profitability And Gross Margin

A gross margin near 67% provides a favorable base for converting revenue growth into earnings as scale improves. Positive EBITDA and sharply reduced losses suggest the commercial model is moving toward sustainability, although consistent GAAP profitability remains to be established.

Expanding Prescriber Adoption

A rapidly expanding prescriber base broadens the company’s commercial reach and reduces dependence on a small group of customers. Sustained physician adoption can support repeat prescription growth, improve brand awareness, and create a stronger platform for future dermatology products.

Bears Say

Negative Cash Generation

Persistent negative operating and free cash flow means reported commercial progress has not yet translated into self-funded operations. Continued cash burn could constrain investment capacity or require additional financing, making durable financial improvement dependent on better cash conversion.

Payer And Formulary Friction

Limited high-quality coverage can delay prescriptions, increase administrative barriers, and reduce realized demand even when physicians favor the product. Because future ASP improvement and sales acceleration depend on formulary progress, payer execution remains a material constraint on growth.

Profitability Remains Unproven

The company has improved materially, but ongoing operating and net losses show that its business model has not yet demonstrated durable profitability. Until revenue growth consistently exceeds commercial and operating costs, earnings remain vulnerable to execution setbacks and investment requirements.

Journey Medical Corp News

DERM FAQ

What was Journey Medical Corp’s price range in the past 12 months?
Journey Medical Corp lowest stock price was $4.25 and its highest was $9.56 in the past 12 months.
What is Journey Medical Corp’s market cap?
Journey Medical Corp’s market cap is $124.75M.
When is Journey Medical Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Journey Medical Corp’s earnings last quarter?
Journey Medical Corp released its earnings results on Nov 12, 2026. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of -$0.02 by -$0.03.
Is Journey Medical Corp overvalued?
According to Wall Street analysts Journey Medical Corp’s price is currently Undervalued.
Does Journey Medical Corp pay dividends?
Journey Medical Corp does not currently pay dividends.
What is Journey Medical Corp’s EPS estimate?
Journey Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Journey Medical Corp have?
Journey Medical Corp has 22,224,396 shares outstanding.
What happened to Journey Medical Corp’s price movement after its last earnings report?
Journey Medical Corp reported an EPS of -$0.05 in its last earnings report, missing expectations of -$0.02. Following the earnings report the stock price went up 3.421%.
Which hedge fund is a major shareholder of Journey Medical Corp?
Hedge funds hold Journey Medical Corp shares: the largest hedge-fund position in Journey Medical Corp is 71,887,849 shares, and hedge funds decreased their holdings by 871.9K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology